InvestSMART

Bio-Gene Technology Ltd (ASX: BGT) - Announcements

Current share price for BGT : $0.016 0.001 (6.67%)+

ASX company news and announcements for Bio-Gene Technology Ltd (BGT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bio-Gene Technology Ltd (BGT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bio-Gene Technology Ltd (BGT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bio-Gene Technology Ltd (BGT)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$7 Application for quotation of securities - BGT 21 Jul 2025 8:26AM $0.018 $0.016 fallen by 11.11%
$7 Notification of cessation of securities - BGT 21 Jul 2025 8:26AM $0.018 $0.016 fallen by 11.11%
$7 Results of Meeting 14 Jul 2025 4:46PM $0.018 $0.016 fallen by 11.11%
$7 Options Prospectus 11 Jul 2025 5:59PM $0.019 $0.016 fallen by 15.79%
$7 Notice of Extraordinary General Meeting/Proxy Form 13 Jun 2025 9:48AM $0.020 $0.016 fallen by 20%
$7 Application for quotation of securities - BGT 4 Jun 2025 12:37PM $0.021 $0.016 fallen by 23.81%
$7 Result of Security Purchase Plan 2 Jun 2025 9:44AM $0.022 $0.016 fallen by 27.27%
$7 Change in substantial holding - DCL 14 May 2025 1:24PM $0.022 $0.016 fallen by 27.27%
$7 Becoming a substantial holder - AB 14 May 2025 1:22PM $0.022 $0.016 fallen by 27.27%
$7 Notice under section 708A(5)(e) of the Corporations Act 2001 12 May 2025 3:17PM $0.023 $0.016 fallen by 30.43%
$7 Application for quotation of securities - BGT 12 May 2025 12:00PM $0.023 $0.016 fallen by 30.43%
$7 Launch of Security Purchase Plan 12 May 2025 11:02AM $0.023 $0.016 fallen by 30.43%
$7 Update - Proposed issue of securities - BGT 5 May 2025 2:53PM $0.027 $0.016 fallen by 40.74%
$7 Proposed issue of securities - BGT 5 May 2025 1:55PM $0.027 $0.016 fallen by 40.74%
$7 Investor Presentation - Placement 5 May 2025 10:24AM $0.025 $0.016 fallen by 36%
$7 Result of Placement 5 May 2025 9:48AM $0.025 $0.016 fallen by 36%
$7 Trading Halt 1 May 2025 9:27AM $0.025 $0.016 fallen by 36%
$7 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2025 8:10AM $0.022 $0.016 fallen by 27.27%
$7 Bio-Gene Presentation - NWR Virtual Healthcare Conference 20 Mar 2025 9:29AM $0.033 $0.016 fallen by 51.52%
$7 BGT to present at virtual healthcare 17 Mar 2025 8:20AM $0.030 $0.016 fallen by 46.67%
$7 Appendix 4D and Half-Year Accounts 31 December 2024 27 Feb 2025 6:09PM $0.033 $0.016 fallen by 51.52%
$7 BGT Investor Webinar 4-Feb-25 Slides 4 Feb 2025 10:28AM $0.045 $0.016 fallen by 64.44%
$7 Investor Webinar Tue 4 Feb 2025 31 Jan 2025 11:49AM $0.045 $0.016 fallen by 64.44%
$7 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2025 8:24AM $0.053 $0.016 fallen by 69.81%
$7 BGT Awarded U.S. Department of Defense Grants 29 Jan 2025 9:15AM $0.032 $0.016 fallen by 50%

76 - 100 of 485 results

Page 4 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.